Answer
Taking fluvastatin with systemic fusidic acid may increase the risk of myopathy, including rhabdomyolysis with reported fatalities, so fluvastatin should be discontinued throughout systemic fusidic acid treatment.
Sources for this answer
- Fluvastatin 20 mg CapsulesSandoz Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 9Document updated
Sources checked